Logo for uniQure N.V.

uniQure Investor Relations Material

Latest events

Logo for uniQure N.V.

Study Update

Logo for uniQure

Q1 2024

7 May, 2024
Logo for uniQure

Q4 2023

28 Feb, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from uniQure N.V.

Access all reports
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Through its adeno-associated virus (AAV) based gene therapy platform, the company develops proprietary power gene therapies that can be used to treat diseases with a high unmet need. Its lead program is focused on Hemophilia B and Huntington's disease.